| Year |
Citation |
Score |
| 2019 |
Klinger RY, Cooter M, Bisanar T, Terrando N, Berger M, Podgoreanu MV, Stafford-Smith M, Newman MF, Mathew JP, Blumenthal JA, Karhausen JA, Kertai MD, Krishnamoorthy V, Li YJ, Swaminathan M, ... ... Strittmatter WJ, et al. Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. PMID 30870159 DOI: 10.1097/Aln.0000000000002668 |
0.352 |
|
| 2018 |
Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Strittmatter WJ, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103 |
0.382 |
|
| 2013 |
Popiel HA, Takeuchi T, Burke JR, Strittmatter WJ, Toda T, Wada K, Nagai Y. Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 440-6. PMID 23504628 DOI: 10.1007/s13311-013-0184-7 |
0.389 |
|
| 2012 |
Strittmatter WJ. Medicine. Old drug, new hope for Alzheimer's disease. Science (New York, N.Y.). 335: 1447-8. PMID 22442467 DOI: 10.1126/science.1220725 |
0.366 |
|
| 2011 |
Popiel HA, Burke JR, Strittmatter WJ, Oishi S, Fujii N, Takeuchi T, Toda T, Wada K, Nagai Y. The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases. Journal of Amino Acids. 2011: 265084. PMID 22312459 DOI: 10.4061/2011/265084 |
0.391 |
|
| 2010 |
Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, Strittmatter WJ, Burke JR, Hulette CM, Welsh-Bohmer KA, Goldstein DB. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 69-77. PMID 20061627 DOI: 10.3233/JAD-2010-1212 |
0.473 |
|
| 2009 |
Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciūte D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. Plos Genetics. 5: e1000373. PMID 19197363 DOI: 10.1371/Journal.Pgen.1000373 |
0.429 |
|
| 2009 |
Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperavičiūtė D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, et al. Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia Plos Genetics. 5. DOI: 10.1371/Annotation/E0196Ebb-De40-453F-8F8C-791B126618Da |
0.399 |
|
| 2008 |
Weinberg JB, Volkheimer AD, Mihovilovic M, Jiang N, Chen Y, Bond K, Moore JO, Gockerman JP, Diehl LF, de Castro CM, Rizzieri DA, Levesque MC, Dekroon R, Strittmatter WJ. Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia. 22: 2184-92. PMID 18784741 DOI: 10.1038/leu.2008.241 |
0.31 |
|
| 2007 |
Hamuro L, Zhang G, Tucker TJ, Self C, Strittmatter WJ, Burke JR. Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay. Assay and Drug Development Technologies. 5: 629-36. PMID 17939755 DOI: 10.1089/adt.2007.083 |
0.307 |
|
| 2007 |
Osorio C, Sullivan PM, He DN, Mace BE, Ervin JF, Strittmatter WJ, Alzate O. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice. Neurobiology of Aging. 28: 1853-62. PMID 17050040 DOI: 10.1016/j.neurobiolaging.2006.08.011 |
0.698 |
|
| 2007 |
Weinberg JB, Volkheimer AD, Mihovilovic M, Jiang N, Chen Y, Moore JO, Gockerman JP, Diehl LF, Castro CMd, Rizzieri DA, Levesque MC, DeKroon R, Strittmatter WJ. Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia. Blood. 110: 3081-3081. DOI: 10.1182/Blood.V110.11.3081.3081 |
0.331 |
|
| 2006 |
Kenan DJ, Strittmatter WJ, Burke JR. Phage display screening for peptides that inhibit polyglutamine aggregation. Methods in Enzymology. 413: 253-73. PMID 17046401 DOI: 10.1016/S0076-6879(06)13014-1 |
0.361 |
|
| 2004 |
Popiel HA, Nagai Y, Onodera O, Inui T, Fujikake N, Urade Y, Strittmatter WJ, Burke JR, Ichikawa A, Toda T. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity. Biochemical and Biophysical Research Communications. 317: 1200-6. PMID 15094397 DOI: 10.1016/j.bbrc.2004.03.161 |
0.353 |
|
| 2004 |
Lai TS, Tucker T, Burke JR, Strittmatter WJ, Greenberg CS. Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. Journal of Neurochemistry. 88: 1253-60. PMID 15009681 DOI: 10.1046/j.1471-4159.2003.02249.x |
0.307 |
|
| 2004 |
Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, Strittmatter WJ, Schmechel DE, Vitek MP. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. Journal of Neuroimmunology. 147: 62-7. PMID 14741429 DOI: 10.1016/J.Jneuroim.2003.10.015 |
0.352 |
|
| 2003 |
Nagai Y, Fujikake N, Ohno K, Higashiyama H, Popiel HA, Rahadian J, Yamaguchi M, Strittmatter WJ, Burke JR, Toda T. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Human Molecular Genetics. 12: 1253-9. PMID 12761040 DOI: 10.1093/hmg/ddg144 |
0.371 |
|
| 2003 |
DeKroon RM, Mihovilovic M, Goodger ZV, Robinette JB, Sullivan PM, Saunders AM, Strittmatter WJ. ApoE genotype-specific inhibition of apoptosis. Journal of Lipid Research. 44: 1566-73. PMID 12754278 DOI: 10.1194/Jlr.M300097-Jlr200 |
0.335 |
|
| 2003 |
Panov AV, Burke JR, Strittmatter WJ, Greenamyre JT. In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Archives of Biochemistry and Biophysics. 410: 1-6. PMID 12559971 DOI: 10.1016/S0003-9861(02)00585-4 |
0.32 |
|
| 2002 |
Swaminathan M, McCreath BJ, Phillips-Bute BG, Newman MF, Mathew JP, Smith PK, Blumenthal JA, Stafford-Smith M, Grocott HP, Hill SE, Reves JG, Schwinn DA, Warner D, Harris M, Kirchner JL, ... ... Strittmatter WJ, et al. Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction Anesthesia and Analgesia. 95: 1-8. PMID 12088934 DOI: 10.1097/00000539-200207000-00001 |
0.588 |
|
| 2002 |
Strittmatter WJ, Bova Hill C. Molecular biology of apolipoprotein E. Current Opinion in Lipidology. 13: 119-23. PMID 11891413 DOI: 10.1097/00041433-200204000-00002 |
0.351 |
|
| 2002 |
Grigore AM, Grocott HP, Mathew JP, Phillips-Bute B, Stanley TO, Butler A, Landolfo KP, Reves JG, Blumenthal JA, Newman MF, Clements FM, De Bruijn N, Grichnik K, Hill SE, Hilton AK, ... ... Strittmatter WJ, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery Anesthesia and Analgesia. 94: 4-10. PMID 11772792 DOI: 10.1097/00000539-200201000-00002 |
0.443 |
|
| 2001 |
Strittmatter WJ. Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms. Biochemical Society Symposium. 101-9. PMID 11447826 DOI: 10.1042/Bss0670101 |
0.419 |
|
| 2001 |
Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P, Goldgaber D. Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. Neurobiology of Aging. 22: 517-28. PMID 11445251 DOI: 10.1016/S0197-4580(00)00248-7 |
0.329 |
|
| 2001 |
Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice. Experimental Neurology. 169: 13-22. PMID 11312553 DOI: 10.1006/exnr.2001.7631 |
0.628 |
|
| 2000 |
Strittmatter WJ. Apolipoprotein E and Alzheimer's disease. Annals of the New York Academy of Sciences. 924: 91-2. PMID 11193808 DOI: 10.1111/J.1749-6632.2000.Tb05565.X |
0.401 |
|
| 2000 |
Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Archives of Neurology. 57: 1561-5. PMID 11074787 DOI: 10.1001/Archneur.57.11.1561 |
0.408 |
|
| 2000 |
Saunders AM, Trowers MK, Shimkets RA, Blakemore S, Crowther DJ, Mansfield TA, Wallace DM, Strittmatter WJ, Roses AD. The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochimica Et Biophysica Acta. 1502: 85-94. PMID 10899434 DOI: 10.1016/S0925-4439(00)00035-1 |
0.58 |
|
| 2000 |
Nagai Y, Tucker T, Ren H, Kenan DJ, Henderson BS, Keene JD, Strittmatter WJ, Burke JR. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. The Journal of Biological Chemistry. 275: 10437-42. PMID 10744733 DOI: 10.1074/Jbc.275.14.10437 |
0.347 |
|
| 2000 |
Hulette CM, Pannell C, Ervin JF, Rosenberg CK, Saunders AM, Strittmatter WJ, Schmechel DE. Vascular abnormalities in APOE4,4 and APOE3,3 Alzheimer's disease Neurobiology of Aging. 21: 271. DOI: 10.1016/S0197-4580(00)83173-5 |
0.388 |
|
| 1999 |
Nagai Y, Onodera O, Strittmatter WJ, Burke JR. Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network. Annals of the New York Academy of Sciences. 893: 192-202. PMID 10672238 DOI: 10.1111/J.1749-6632.1999.Tb07826.X |
0.355 |
|
| 1999 |
Nagai Y, Onodera O, Chun J, Strittmatter WJ, Burke JR. Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network. Experimental Neurology. 155: 195-203. PMID 10072295 DOI: 10.1006/exnr.1998.6991 |
0.356 |
|
| 1999 |
Cooper AJ, Sheu KF, Burke JR, Strittmatter WJ, Gentile V, Peluso G, Blass JP. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. Journal of Neurochemistry. 72: 889-99. PMID 10037459 DOI: 10.1046/j.1471-4159.1999.0720889.x |
0.359 |
|
| 1998 |
Cooper AJ, Sheu KF, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP. Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions? Age. 21: 25-30. PMID 23604331 DOI: 10.1007/S11357-998-0004-X |
0.555 |
|
| 1998 |
Fullerton SM, Strittmatter WJ, Matthew WD. Peripheral sensory nerve defects in apolipoprotein E knockout mice. Experimental Neurology. 153: 156-63. PMID 9743578 DOI: 10.1006/exnr.1998.6872 |
0.62 |
|
| 1998 |
Scott BL, Welch K, deSerrano V, Moss NC, Roses AD, Strittmatter WJ. Human apolipoprotein E accelerates microtubule polymerization in vitro. Neuroscience Letters. 245: 105-8. PMID 9605496 DOI: 10.1016/S0304-3940(98)00180-3 |
0.562 |
|
| 1998 |
Guyton JR, Miller SE, Martin ME, Khan WA, Roses AD, Strittmatter WJ. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid. Journal of Neurochemistry. 70: 1235-40. PMID 9489746 DOI: 10.1046/J.1471-4159.1998.70031235.X |
0.49 |
|
| 1998 |
Cooper AJL, Sheu KFR, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP. Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly- Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions? Age. 21: 25-30. |
0.426 |
|
| 1997 |
Cooper AJ, Sheu KR, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proceedings of the National Academy of Sciences of the United States of America. 94: 12604-9. PMID 9356496 DOI: 10.1073/Pnas.94.23.12604 |
0.497 |
|
| 1997 |
Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD, Croughwell ND, Davis RD, Roses AD, Reves JG. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. The Annals of Thoracic Surgery. 64: 715-20. PMID 9307463 DOI: 10.1016/S0003-4975(97)00757-1 |
0.468 |
|
| 1997 |
Onodera O, Burke JR, Miller SE, Hester S, Tsuji S, Roses AD, Strittmatter WJ. Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells. Biochemical and Biophysical Research Communications. 238: 599-605. PMID 9299559 DOI: 10.1006/Bbrc.1997.7337 |
0.524 |
|
| 1997 |
Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 6114-21. PMID 9236223 DOI: 10.1523/Jneurosci.17-16-06114.1997 |
0.638 |
|
| 1997 |
Cooper AJ, Sheu KF, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP. Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases? Journal of Neurochemistry. 69: 431-4. PMID 9202340 DOI: 10.1046/J.1471-4159.1997.69010431.X |
0.49 |
|
| 1996 |
Strittmatter WJ, Burke JR, DeSerrano VS, Huang DY, Matthew W, Saunders AM, Scott BL, Vance JM, Weisgraber KH, Roses AD. Protein: protein interactions in Alzheimer's disease and the CAG triplet repeat diseases. Cold Spring Harbor Symposia On Quantitative Biology. 61: 597-605. PMID 9246486 DOI: 10.1101/Sqb.1996.061.01.060 |
0.739 |
|
| 1996 |
Onodera O, Roses AD, Tsuji S, Vance JM, Strittmatter WJ, Burke JR. Toxicity of expanded polyglutamine-domain proteins in Escherichia coli. Febs Letters. 399: 135-9. PMID 8980137 DOI: 10.1016/S0014-5793(96)01301-4 |
0.526 |
|
| 1996 |
Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annual Review of Neuroscience. 19: 53-77. PMID 8833436 DOI: 10.1146/Annurev.Ne.19.030196.000413 |
0.588 |
|
| 1996 |
Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ. Crosslinking of apolipoprotein E by products of lipid peroxidation. Journal of Neuropathology and Experimental Neurology. 55: 202-10. PMID 8786379 DOI: 10.1097/00005072-199602000-00009 |
0.56 |
|
| 1996 |
Saunders AM, Hulette O, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JC, Rosenberg C. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (London, England). 348: 90-3. PMID 8676723 DOI: 10.1016/S0140-6736(96)01251-2 |
0.375 |
|
| 1996 |
Roses AD, Einstein G, Gilbert J, Goedert M, Han SH, Huang D, Hulette C, Masliah E, Pericak-Vance MA, Saunders AM, Schmechel DE, Strittmatter WJ, Weisgraber KH, Xi PT. Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism. Annals of the New York Academy of Sciences. 777: 146-57. PMID 8624078 DOI: 10.1111/J.1749-6632.1996.Tb34413.X |
0.634 |
|
| 1996 |
Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Experimental Neurology. 138: 252-60. PMID 8620924 DOI: 10.1006/Exnr.1996.0064 |
0.421 |
|
| 1996 |
Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM, Strittmatter WJ. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Medicine. 2: 347-50. PMID 8612237 DOI: 10.1038/Nm0396-347 |
0.528 |
|
| 1996 |
Roses AD, Burke JR, Vance JM, Strittmatter WJ. Reply to “A role for GAPDH in apoptosis and neurodegeneration” Nature Medicine. 2: 610-610. DOI: 10.1038/Nm0696-610A |
0.403 |
|
| 1996 |
Roses A, Saunders A, Hulette C, Welsh K, Crain B, Burke J, Alberts M, Strittmatter W, Breitner J, Earl N, Clark C, Heyman A, Gaskell P, Pericak-Vance M. 295 Predictive value of APOE genotyping in a consecutive series of autopsied sporadic probable Alzheimer disease patients Neurobiology of Aging. 17: S74. DOI: 10.1016/S0197-4580(96)80297-1 |
0.538 |
|
| 1996 |
Roses A, Saunders A, Pericak-Vance M, Einstein G, Hulette C, Schmechel D, Huang D, Strittmatter W. Apolipoprotein is a susceptibility genetic locus that affects the expression of late-onset familial and sporadic Alzheimer's disease Biological Psychiatry. 39: 562. DOI: 10.1016/0006-3223(96)84162-X |
0.618 |
|
| 1995 |
Roses AD, Saunders AM, Alberts MA, Strittmatter WJ, Schmechel D, Gorder E, Pericak-Vance MA. Apolipoprotein E E4 allele and risk of dementia. Jama. 273: 374-5; author reply . PMID 7823377 DOI: 10.1001/Jama.1995.03520290026015 |
0.535 |
|
| 1995 |
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Roses AD, Pericak-Vance MA, Small GW, Haines JL. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. Jama. 273: 373-4. PMID 7823376 DOI: 10.1001/jama.1995.03520290025013 |
0.492 |
|
| 1995 |
Roses AD, Saunders AM, Strittmatter WJ, Schmechel DE, Pericak-Vance MA, Hyman B. Apolipoprotein E in Creutzfeldt-Jacob disease. Lancet. 345: 69. PMID 7799733 |
0.475 |
|
| 1995 |
Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 4725-7. PMID 7761390 DOI: 10.1073/pnas.92.11.4725 |
0.623 |
|
| 1995 |
Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346: 575. PMID 7658797 DOI: 10.1016/S0140-6736(95)91411-0 |
0.464 |
|
| 1995 |
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 45: 1323-8. PMID 7617191 DOI: 10.1212/Wnl.45.7.1323 |
0.385 |
|
| 1995 |
Huang DY, Weisgraber KH, Goedert M, Saunders AM, Roses AD, Strittmatter WJ. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neuroscience Letters. 192: 209-12. PMID 7566652 DOI: 10.1016/0304-3940(95)11649-H |
0.635 |
|
| 1995 |
Huang DY, Weisgraber KH, Strittmatter WJ, Matthew WD. Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Experimental Neurology. 136: 251-7. PMID 7498414 DOI: 10.1006/Exnr.1995.1101 |
0.676 |
|
| 1995 |
Strittmatter WJ, Roses AD. Apolipoprotein E: Emerging Story in the Pathogenesis of Alzheimer's Disease The Neuroscientist. 1: 298-306. DOI: 10.1177/107385849500100507 |
0.603 |
|
| 1995 |
Roses A, Saunders A, Pericak-Vance M, Schmechel D, Strittmatter W. Apoliporotein E is a susceptibility locus for Alzheimer disease Pharmacological Research. 31: 16. DOI: 10.1016/1043-6618(95)86323-0 |
0.571 |
|
| 1994 |
Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Experimental Neurology. 125: 163-71; discussion 1. PMID 8313935 DOI: 10.1006/Exnr.1994.1019 |
0.569 |
|
| 1994 |
Roses AD, Pericak-Vance MA, Saunders AM, Schmechel D, Goldgaber D, Strittmatter W. Complex genetic disease: can genetic strategies in Alzheimer's disease and new genetic mechanisms be applied to epilepsy? Epilepsia. 35: S20-8. PMID 8293721 DOI: 10.1111/J.1528-1157.1994.Tb05925.X |
0.532 |
|
| 1994 |
Whitson JS, Mims MP, Strittmatter WJ, Yamaki T, Morrisett JD, Appel SH. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochemical and Biophysical Research Communications. 199: 163-70. PMID 8123007 DOI: 10.1006/bbrc.1994.1209 |
0.392 |
|
| 1994 |
Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM, Pericak-Vance M, Roses AD, Schmechel DE. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. Journal of Neuropathology and Experimental Neurology. 53: 535-44. PMID 8083695 DOI: 10.1097/00005072-199409000-00013 |
0.536 |
|
| 1994 |
Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proceedings of the National Academy of Sciences of the United States of America. 91: 8368-72. PMID 8078889 DOI: 10.1073/Pnas.91.18.8368 |
0.377 |
|
| 1994 |
Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Experimental Neurology. 128: 13-26. PMID 8070517 DOI: 10.1006/Exnr.1994.1108 |
0.584 |
|
| 1994 |
Weisgraber KH, Roses AD, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Current Opinion in Lipidology. 5: 110-6. PMID 8044413 DOI: 10.1097/00041433-199404000-00007 |
0.554 |
|
| 1994 |
Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 91: 11183-6. PMID 7972031 DOI: 10.1073/Pnas.91.23.11183 |
0.655 |
|
| 1994 |
Goedert M, Strittmatter WJ, Roses AD. Alzheimer's disease. Risky apolipoprotein in brain. Nature. 372: 45-6. PMID 7969418 DOI: 10.1038/372045A0 |
0.533 |
|
| 1994 |
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics. 7: 180-4. PMID 7920638 DOI: 10.1038/Ng0694-180 |
0.388 |
|
| 1994 |
Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet. 343: 1564-5. PMID 7911881 DOI: 10.1016/S0140-6736(94)92960-2 |
0.499 |
|
| 1994 |
Huang DY, Goedert M, Jakes R, Weisgraber KH, Garner CC, Saunders AM, Pericak-Vance MA, Schmechel DE, Roses AD, Strittmatter WJ. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease. Neuroscience Letters. 182: 55-8. PMID 7891887 DOI: 10.1016/0304-3940(94)90204-6 |
0.661 |
|
| 1994 |
Roses AD, Saunders AM, Alberts MJ, Strittmatter WJ, Schmechel DE. Apolipoprotein E 4 Neurology. 44: 2421-2421. DOI: 10.1212/Wnl.44.12.2421 |
0.477 |
|
| 1994 |
Roses A, Saunders A, Corder E, Risch N, Haines J, Pericak-Vance M, Han S, Einstein G, Hulette C, Schmechel D, Goedert M, Jakes R, Dong L, Weisgraber K, Holsti M, ... ... Strittmatter W, et al. Apolipoprotein E-e4 and apolipoprotein E-e2 are susceptibility genes that affect the rate of disease expressivity of late-onset familial and sporadic Alzheimer disease Journal of the Neurological Sciences. 127: 2. DOI: 10.1016/0022-510X(94)90109-0 |
0.622 |
|
| 1993 |
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 90: 1977-81. PMID 8446617 DOI: 10.1073/Pnas.90.5.1977 |
0.595 |
|
| 1993 |
Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 90: 9649-53. PMID 8415756 DOI: 10.1073/Pnas.90.20.9649 |
0.559 |
|
| 1993 |
Strittmatter WJ, Huang DY, Bhasin R, Roses AD, Goldgaber D. Avid binding of beta A amyloid peptide to its own precursor. Experimental Neurology. 122: 327-34. PMID 8405269 DOI: 10.1006/Exnr.1993.1132 |
0.607 |
|
| 1993 |
Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 90: 8098-102. PMID 8367470 DOI: 10.1073/Pnas.90.17.8098 |
0.615 |
|
| 1993 |
Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43: 1467-72. PMID 8350998 DOI: 10.1212/Wnl.43.8.1467 |
0.422 |
|
| 1993 |
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (New York, N.Y.). 261: 921-3. PMID 8346443 DOI: 10.1126/Science.8346443 |
0.551 |
|
| 1993 |
Goldgaber D, Schwarzman AI, Bhasin R, Gregori L, Schmechel D, Saunders AM, Roses AD, Strittmatter WJ. Sequestration of amyloid beta-peptide. Annals of the New York Academy of Sciences. 695: 139-43. PMID 8239272 DOI: 10.1111/J.1749-6632.1993.Tb23042.X |
0.517 |
|
| 1993 |
Huang D, Martin M, Hu D, Roses AD, Goldgaber D, Strittmatter WJ. Binding of IgG to amyloid beta A4 peptide via the heavy-chain hinge region with preservation of antigen binding. Journal of Neuroimmunology. 48: 199-203. PMID 8227317 DOI: 10.1016/0165-5728(93)90192-2 |
0.589 |
|
| 1992 |
Roses A, Alberts M, Strittmatter W. Alzheimer's disease - reassessing the data Current Biology. 2: 7-9. DOI: 10.1016/0960-9822(92)90400-5 |
0.543 |
|
| 1989 |
Appel SH, McManaman JL, Strittmatter WJ. Will neurotrophic agents be harmful in Alzheimer's disease? Neurobiology of Aging. 10: 580-1; discussion 58. PMID 2812232 DOI: 10.1016/0197-4580(89)90136-X |
0.359 |
|
| 1989 |
Pirozzolo FJ, Inbody SB, Sims PA, Strittmatter WJ, Baskin D. Neuropathological and neuropsychological changes in Alzheimer's disease. Relationship of biologic markers to behavioral markers. Clinics in Geriatric Medicine. 5: 425-40. PMID 2680026 DOI: 10.1016/S0749-0690(18)30663-3 |
0.384 |
|
| 1981 |
Hirata F, Tallman JF, Henneberry RC, Mallorga P, Strittmatter WJ, Axelrod J. Phospholipid methylation: a possible mechanism of signal transduction across biomembranes. Progress in Clinical and Biological Research. 63: 383-8. PMID 6273927 |
0.591 |
|
| 1981 |
Strittmatter WJ, Hirata F, Axelrod J. Regulation of the beta-adrenergic receptor by methylation of membrane phospholipids. Advances in Cyclic Nucleotide Research. 14: 83-91. PMID 6269406 |
0.364 |
|
| 1980 |
Hirata F, Tallman JF, Henneberry RC, Mallorga P, Strittmatter WJ, Axelrod J. Regulation of beta-adrenergic receptors by phospholipid methylation. Advances in Biochemical Psychopharmacology. 21: 91-7. PMID 6246762 |
0.578 |
|
| 1979 |
Strittmatter WJ, Hirata F, Axelrod J. Phospholipid methylation unmasks cryptic beta-adrenergic receptors in rat reticulocytes. Science (New York, N.Y.). 204: 1205-7. PMID 221977 DOI: 10.1126/Science.221977 |
0.455 |
|
| 1979 |
Strittmatter WJ, Hirata F, Axelrod J. Increased Ca2+ -ATPase activity associated with methylation of phospholipids in human erythrocytes. Biochemical and Biophysical Research Communications. 88: 147-53. PMID 156544 DOI: 10.1016/0006-291X(79)91709-1 |
0.404 |
|
| 1979 |
Strittmatter WJ, Hirata F, Axelrod J, Mallorga P, Tallman JF, Henneberry RC. Benzodiazepine and beta-adrenergic receptor ligands independently stimulate phospholipid methylation. Nature. 282: 857-9. PMID 42020 DOI: 10.1038/282857a0 |
0.607 |
|
| 1979 |
Hirata F, Strittmatter WJ, Axelrod J. beta-Adrenergic receptor agonists increase phospholipid methylation, membrane fluidity, and beta-adrenergic receptor-adenylate cyclase coupling. Proceedings of the National Academy of Sciences of the United States of America. 76: 368-72. PMID 34151 DOI: 10.1073/Pnas.76.1.368 |
0.442 |
|
| 1978 |
Strittmatter WJ, Gagnon C, Axelrod J. Beta adrenergic stimulation of protein carboxymethylation and amylase secretion in rat parotid gland. The Journal of Pharmacology and Experimental Therapeutics. 207: 419-24. PMID 712630 DOI: 10.1016/B978-1-4832-8363-0.50121-X |
0.455 |
|
| 1977 |
Strittmatter WJ, Davis JN, Lefkowitz RJ. alpha-Adrenergic receptors in rat parotid cells. II. Desensitization of receptor binding sites and potassium release. The Journal of Biological Chemistry. 252: 5478-82. PMID 195951 |
0.322 |
|
| 1977 |
Strittmatter WJ, Davis JN, Lefkowitz RJ. alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux. The Journal of Biological Chemistry. 252: 5472-7. PMID 195950 |
0.319 |
|
| Show low-probability matches. |
